cryptomedix.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: | ||
Meta Tags
| Title | CryptoMedix | Targeting the tumor |
| Description | CryptoMedix is a biotech company in the field of Oncology, developing highly innovative anticancer |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 208.109.25.221 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cryptomedix.com Valuation
|
US$1,274
Last updated: 2023-05-19 19:14:50
cryptomedix.com has Semrush global rank of 0. cryptomedix.com has an estimated worth of US$ 1,274, based on its estimated Ads revenue. cryptomedix.com receives approximately 147 unique visitors each day. Its web server is located in United States, with IP address 208.109.25.221. According to SiteAdvisor, cryptomedix.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,274 |
| Daily Ads Revenue | US$1 |
| Monthly Ads Revenue | US$35 |
| Yearly Ads Revenue | US$423 |
| Daily Unique Visitors | 9 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cryptomedix.com. | A | 10799 | IP: 208.109.25.221 |
| cryptomedix.com. | NS | 3600 | NS Record: ns41.domaincontrol.com. |
| cryptomedix.com. | NS | 3600 | NS Record: ns42.domaincontrol.com. |
| cryptomedix.com. | TXT | 3600 | TXT Record: google-site-verification=LCkgZWw66XkhwA1WSxByxbvg4t2wq9j2QBujq30dO8s |
HtmlToTextCheckTime:2023-05-19 19:14:50
| Targeting the tumor microenvironment New Website Coming Soon A letter to CryptoMedix Founders and Shareholders Despite another challenging COVID-19 year for the biotech industry, CryptoMedix Inc. has continued to make excellent scientific progress through the lab: The CryptoMedix story in now squarely in the hot immuno-oncology and TME (tumor microenvironment) space as the major mechanism of action (MOA) of our technology platform: Our first-in-class therapeutic antibodies promote the migration/function of cytotoxic T-cells (which kill tumor cells), and inhibit the migration/function of tumor-suppressive macrophages in the TME. Moreover, there is exciting synergy of CMX-101 and -102 with PD(L)1 immune-checkpoint inhibitors, based on a novel and unique mechanism of action (MOA), i.e., through proteasome-mediated degradation of the PDL1 protein. This has resulted in two newly issued U.S. patents - which is important since our old composition of matter patents have meanwhile expired. |
HTTP Headers
HTTP/1.1 302 Found Date: Sat, 12 Nov 2022 08:30:15 GMT Server: Apache Location: https://www.cryptomedix.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 last-modified: Fri, 31 Dec 2021 06:43:46 GMT etag: "19240ec-3731-5d46b7e2959e6" accept-ranges: bytes content-length: 14129 vary: Accept-Encoding content-type: text/html date: Sat, 12 Nov 2022 08:30:16 GMT server: Apache |
cryptomedix.com Whois Information
Domain Name: CRYPTOMEDIX.COM Registry Domain ID: 1902604935_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2022-10-18T01:08:53Z Creation Date: 2015-02-13T17:14:41Z Registry Expiry Date: 2023-02-13T17:14:41Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS41.DOMAINCONTROL.COM Name Server: NS42.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-11-12T08:24:25Z <<< |